Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totaling 17,947 shares, a decrease of 27.2% from the December 31st total of 24,659 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average daily volume of 48,014 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 48,014 shares, the days-to-cover ratio is currently 0.4 days. Approximately 1.6% of the shares of the stock are sold short.
Mannatech Stock Down 0.8%
NASDAQ MTEX opened at $7.45 on Friday. The company has a quick ratio of 0.56, a current ratio of 1.13 and a debt-to-equity ratio of 0.48. Mannatech has a 52 week low of $6.90 and a 52 week high of $13.25. The firm has a market capitalization of $14.16 million, a price-to-earnings ratio of -8.66 and a beta of 0.79. The company has a fifty day moving average of $8.37 and a two-hundred day moving average of $8.70.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its earnings results on Wednesday, November 12th. The company reported $1.01 earnings per share (EPS) for the quarter. The firm had revenue of $29.16 million during the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Mannatech
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Recommended Stories
- Five stocks we like better than Mannatech
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
